Evolutionary Genomics's total assets for Q4 2022 were $2.35M, a decrease of -12.42% from the previous quarter. FNAM total liabilities were $7.95M for the fiscal quarter, a 0.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.